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Male: Effect of an Aromatization Inhibitor in
Estradiol-implanted, Orchidectomized Dogs
C. AWONIYI, T. HASSON, V. CHANDRASHEKAR, R. E. FALVO,
AND B. D. SCHANBACHER*
Testosterone is aromatized to estradiol in both peripheral
tissues and the central nervous system. Various authors
have suggested that this conversion in the male may be
prerequisite for the regulation of gonadotropin secretion
by testosterone. Previously, it was reported that inhibi-
tion of central nervous system aromatase caused a signifi-
cant increase in plasma LH in the presence of physiologic
testosterone levels (Winter et a!, 1983). In order to con-
firm whether aminoglutethimide, the aromatase inhibi-
tor used in our previous study, either blocked aromatiza-
tion, or the action of estradiol, the following study was
conducted. Fifteen male mongrel dogs were equally
divided into three groups. Group 1 dogs were implanted
with estradiol-filled polydimethylsiloxane capsules only;
Group 2 dogs were implanted with empty capsules and
treated with 60 mg b.i.d. of aminoglutethimide; and
Group 3 dogs were implanted with polydimethylsiloxane
capsules filled with estradiol and treated with amino-
glutethimide. Blood samples were drawn for 24 days dur-
ing pretreatment, capsule implantation, castration, ami-
noglutethimide administration and capsule removal peri-
ods. The postcastration response of both plasma LH and
FSH in dogs in groups I and 3 was suppressed in the
presence of elevated estradiol, whereas that of Group 2
dogs was normal in the absence of estradiol. The results
suggest that aminoglutethimide neither directly affects
the plasma concentration of either LH or FSH nor blocks
the effect of estradio! in inhibiting their release following
castration. These data, taken together with our previous
work, implicate aromatization of testosterone to estra-
diol in the control of gonadotropin secretion in the male.
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The role of testosterone (T) in the regulation of
gonadotropin secretion has been studied in a large
number of species, including rats (Swerdloff and
Walsh, 1973; Block et a!, 1974), rams (Gamier et a!,
1977; D’Occhio et a!, 1982), monkeys (Plant et al,
1978; Steiner et a!, 1978) and dogs (DePalatis et al,
1978; Falvo et al, 1979, 1982; Vincent et a!, 1979;
Falvo and Vincent, 1980). However, the question as
to whether T acts directly on the hypothalamus and
pituitary or whether aromatization to E2, or reduc-
tion to dihydrotestosterone (DHT) are required for
its action, remains unanswered (Worgul et al, 1981;
Winter et al, 1983; Schanbacher, 1984).
Although implicated in the control of gonadotrop-
ins by direct interaction with androgen receptors in
the hypothalamic-pituitary unit (Swerdloff and He-
ber, 1980), these effects may be the result of T being
converted to estradiol (E2) intracerebrally (Naftolin
and Ryan, 1975). In the orchidectomized dog, both T
and E2 are effective in reducing the high circulating
levels of LH (Vincent et al, 1979) as well as FSH
(Falvo and Vincent, 1980), whereas DHT is ineffec-
tive (Winter et a!, 1982).
Previous work in our laboratory has indicated that
physiologic levels of T in orchidectomized dogs can
maintain LH chronically (Vincent et al, 1979) and
FSH acutely (Falvo and Vincent, 1980) within the
normal intact range. Furthermore, we also have
shown that the aromatase inhibitor, aminoglutethi-
No.4 REGULATION OF GONADOTROPIN SECRETION Awoniyi et al 235
mide, prevents the ability of T to inhibit the postor-
chidectomy rise of LH in T-imp!anted orchidectomi-
zed dogs despite the presence of normal plasma
concentrations of T and E2 (Winter et al, 1983). These
data suggest that aromatizaiton of T to E2 is a neces-
sary step in the regulation of LH secretion in the male
dog. The lack of change in the peripheral concentra-
tion of E2, in the presence of aminoglutethimide, led
led us to conclude indirectly that inhibition of aro-
matization occurred centrally, rather than peripher-
ally (Winter et al, 1983). Data regarding FSH were
inconclusive since in the absence of aminoglutethi-
mide, T was able to maintain intact levels of FSH in
the orchidectomized dog only acutely (approximately
6 days).
To confirm whether the aromatase inhibitor (ami-
noglutethimide) used in our previous study either
blocked the aromatization of T to E2 or the action of
E2, we have repeated the protocol of our previous
study (Winter et al, 1983), substituting Ez-imp!anta-
tion for T in both the presence or absence of amino-
glutethimide following orchidectomy in the male
dog. These data, with those we reported previously,
further substantiate that the aromatization of T toE2
may be required for the control of gonadotropin
secretion in the male dog.
Methods and Materials
Design
Fifteen healthy, sexually mature male mongrel dogs
were used in this study. They were housed indoors indi-
vidually under controlled lighting (12 h light: 12 h dark)
and temperature. Water and dog chow were available ad
libitum. The dogs were equally divided into three groups.
Group 1 was implanted with E2-filled polydimethylsilox-
ane capsules (PDS-E2). Group 2 was implanted with empty
PDS capsules and treated with aminoglutethimide (Cyta-
dren-AG, Ciba-Geigy Pharmaceuticals, Summit, NJ), while
group 3 was implanted with PDS-E2 and treated with
aminoglutethimide. This aromatase inhibitor (Graves and
Salhanich, 1979) has been used in similar doses in both
dogs (Worgul et al. 1981) and sheep (Schanbacher 1984).
During the 24-day study, the protocol was as follows for
each group: days 1 to 4, intact (untreated); day 4 capsule
implantation; day 8, castration (capsules left in situ); days
14 to 24, aminoglutethimide administration to groups 2
and 3; and day 19, capsule removal. The oral dose of
aminoglutethimide (60 mg bid.) was administered at
1000 hours following blood sampling and again at 1700
hours.
Blood samples were drawn from all dogs for 1 hour at
20-minute intervals. Sampling took place daily for 24 days
via saphenous or cephalic vein puncture. The plasma was
separated by centrifugation, aliquoted, and pooled for
each dog over the 1-hour period, and stored in three
separate plasma vials at -20 C until assayed for E2, LH,
and FSH.
Capsule Preparation
PDS capsule preparation and implantation was done
according to a method previously published by this labora-
tory (Vincent et al, 1979). The capsules (3.35 mm LD X
4.65 mm OD) were implanted subcutaneously in the
shoulder region under general anesthesia at the rate of
7.0-cm capsule length/b kg body weight.
Hormone Assays
Plasma LH was measured by RIA as described pre-
viously by this laboratory (DePalatis et al, 1978). Ovine
LH (LER-1056-62) was used as the radiolabeled antigen.
The first antibody was No. 15 of G.D. Niswender and the
canine standards were purified canine LH (LER-1685-1).
The sensitivity of the assay was 0.02 ng/tube with an
interassay variation of 11%. Plasma FSH was measured by
RIA as described previously by this laboratory. (Winter et
a!, 1982). Ovine FSH (LER-1181-3) was used as the radio-
labeled antigen. The first antibody was M91 (rabbit
antiserum to human FSH) and the standards were purified
canine FSH (LER-1685-3A). The sensitivity of the assay
was 12.5 ng/tube with intra-assay and interassay values of
5.3 and 8.7, respectively. Plasma E2 was measured in dupli-
cate 500-l volumes following extraction in freshly opened
diethyl ether as described previously by this laboratory
(Winter et al, 1983). The antiserum, GDN-E2-6 pro-
vided by GD. Niswender, has 30% displacing ability for
estrone and virtually none for estriol when compared with
E2. Extraction of canine steroid-stripped plasma was con-
sistently undetectable. When 31.2 pg of unlabelled E2 was
added to 1 ml of stripped canine plasma, the mean recov-
ery was 25.7 ± 1.1 (SEM) pg for ten assays. The sensitivity
of this assay was 0.85 pg/tube, and blank values were not
subtracted from obtained values. Following overnight
incubation at 4 C, bound steroid was separated from free
steriod using dextran-coated charcoal.
Statistical Analysis
The significance of treatment effects among groups and
within each group was tested. The statistical analysis
included an analysis of variance followed by comparison of
means by Tukey and Scheffe post-hoc tests at the 95%
confidence limits.
Results
The mean concentration of E2, LH, and FSH
obtained from daily blood samples for the five dogs in
each group are shown in Fig. 1. Tables 1 to 3 show the
mean plasma concentration of these same hormones
for each entire treatment period. There were signifi-
cant treatment effects both between and within the
groups during the experiment.
Table 1 shows the plasma E2 concentrations of the
three groups of dogs. In the dogs implanted with
PDS-E2 capsules (groups 1 and 3), the mean concen-
trations of E2 rose immediately after PDS-E2 capsule
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Fig. 1. Profiles of plasma E2, LH, and FSH in dogs implanted
with E2-filled polydimethylsiloxane capsules (PDS-E2) (group I
*......*..._.*), with empty PDS and treated with aminoglutethimide
(group 20-0-0), and with PDS-E2 and treated with aminoglute-
thimide (group 3--). Means ± SEM are shown in Tables 1,
2, and 3. Dogs were implanted with PDS on day 4, castrated on
day 8, aminoglutethimide administered (groups 2 and 3) twice
daily from days 14 to 19, and the PDS capsules removed on day
19. All treatments were performed following blood sampling.
implantation, and remained elevated until they fell
on day 20 following capsule removal. However, in
group 2 (empty PDS capsule and treated with amino-
glutethimide), the mean plasma E2 concentration fell
following castration on day 8 and remained low
throughout the experiment.
Table 2 shows the plasma LH concentrations of the
three groups of dogs during the different treatment
periods. In group 1, the only significant differences
were found between the period of PDS-E2 implanta-
tion and following castration. In dogs implanted with
empty PDS capsules and treated with aminog!utethi-
mide (group 2), the plasma LH levels rose signifi-
cantly following castration and continued to increase
until the end of the experiment. In group 3 (PDS-E2
and treated with aminoglutethimide), the plasma
levels of LH fell following capsule implantation and
remained low until termination of the experiment.
The capsule implantation and castration periods
were not different from each other but differed sig-
nificantly from all the other periods. The aminoglu-
tethimide treatment and capsule removal periods
were not significantly different from each other.
The mean plasma concentrations of FSH are
shown in Table 3. The plasma FSH levels in group 1
(PDS-E2) and group 3 (PDS-E2 and treated with ami-
noglutethimide) followed a similar trend in that the
plasma FSH values were not affected by E2 treat-
ments. Following capsule removal, FSH concentra-
tions rose in group 1 but not in group 3. In dogs
implanted with empty PDS capsules and treated with
aminog!utethimide (group 2), plasma FSH concen-
trations rose immediately after castration and kept
rising until the end of the experiment.
Discussion
Data collected in various species indicate that
androgens and estrogens regulate LH secretion in
the male (Santen, 1981). It has been shown further
that some of the effects of T on the regulation of LH
secretion are due to T conversion to E2 either cen-
trally and/or peripherally (Worgul et a!, 1981).
Previously, we reported that aminoglutethimide
administration to T-implanted orchidectomized dogs
caused an abrupt rise in plasma LH and indirectly
concluded that central aromatization of T to E2 was a
prerequisite step for feedback regulation (Winter et
al, 1983).
Our conclusions also were supported by other
work in the dog using the same aromatase inhibitor
(Worgu! et a!, 1981). However, our data and that of
Worgu! et a! (1981) could be interpreted to indicate
that aminoglutethimide stimulated LH secretion di-
rectly or inhibited the feedback action of E2 on its
receptor. In the present study, we implanted orchi-
dectomized dogs with E2 and administered aminoglu-
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TABLE 1. Plasma Concentrations of E2 (p9/mI) in Dogs Treated with PDS-E2 (Group 1);
Empty PDS + AG (Group 2); and PDS-E2 + AG (Group 3)
Treatment Days
Group 1
(Mean ± SEM)
Group 2
(Mean ± SEM)
Group 3
(Mean ± SEM)
Pretreatment
PDS
0-4
5-8
9.9 ± O.9Bt
90.6 ± 65B,a
5.6 ± 03A,b
6.0 ± 03A,b
6.2 ± 07B,b
90.9 ± 86A,a
Castration 9-14 89.8 ± 6.2a 2.8 ± 0,3B,b 101.4 ±
AG treatment (not group 1)
PDS removal
15-24
20-24
84.9 ±
8.6 ± 36B,a
3.4 ± 08B,b
3.5 ± 1.3
94.6 ± 93A,a
3.4 ± 05B,a
PDS-E2 = Polydimethylsiloxane capsules filled with estradiol; AG = aminoglutethimide.
tSuperscripts represent significant differences at the 0.05 level. Uppercase superscripts compare the effect of treatments within
each group (vertical comparison). Lowercase superscripts compare the effect of treatments between the groups (horizontal
comparison).
tethimide. No effect of aminoglutethimide was ob-
served, since E2 was able to inhibit both LH and FSH
secretion following orchidectomy. We have concluded
that aminoglutethimide does not affect E2 action
directly.
It is important to note that the concentration of E2
achieved in this study following E2 implantation was
approximately 10 times that found in intact dogs.
This high level of E2 may have been the cause of the
chronic suppression of both LH and FSH observed
following E2 removal in groups 1 and 3 (Fig. 1). In our
previous studies in dogs, removal of T in orchidec-
tomized dogs results in a prompt increase in both
gonadotropins (Vincent et a!, 1979).
The most convincing data regarding E2 involve-
ment in LH regulation in the male are those of Ellin-
wood et a!. (1984), who found that following implan-
tation of male monkeys with an aromatase inhibitor,
1,4,6-androstatriene-3,17,dione (ATD), increases in
both plasma LH and T were observed. If E2 was
administered concurrently with ATD, the effect of
ATD was abolished and neither plasma LH nor T
were affected. ATD treatment was shown to reduce
peripheral E2 levels to 30% and hypothalamic aroma-
tase activity to 10 to 20% of control values. They
concluded, as have we, that E2 formation plays an
important role in the negative feedback regulation of
LH secretion in males. Similar conclusions have been
made in the T-treated orchidectomized ram using
aminoglutethimide treatment (Schanbacher, 1984).
In a previous study (Worgu! eta!, 1981), aminoglu-
tethimide was administered to intact dogs also treated
with hydrocortisone to suppress ACTH and further
suppress adrenal androgen secretion. This regimen
resulted in increased plasma concentrations of LH to
castrate levels within seven days of treatment. Ac-
companying this increase of LH were increases in
plasma concentrations ofT. In constrast to T, plasma
concentrations of E2 remained low. Since aminoglu-
tethimide administration caused an increase in plasma
LH in the presence of increasing plasma concentra-
tions of T and constant levels of peripheral E2, these
authors also concluded that central, rather than pe-
ripheral aromatization, was blocked by the aminoglu-
tethimide.
In contrast to the data obtained in dogs and mon-
keys, it has been reported (Marynick et a!, 1979) that
aromatization is not essential for LH regulation. Men
were pretreated with the aromatase inhibitor testo-
lactone (Teslac, E.R. Squibb, Princeton, NJ) and then
TABLE 2. Plasma Concentrations of LH (ng/ml) in Dogs Treated with PDS-E2 (Group 1);
Empty PDS + AG (Group 2); and PDS-E2 + AG (Group 3)
Treatment Days
Group 1
(Mean ± SEM)
Group 2
(Mean ± SEM)
Group 3
(Mean ± SEM)
Pretreatment 0-.4 1.1 ± 02AB’a 1.5 ± O.4’ 1.8 ±
PDS 5-8 0.1 ± 002B’b 2.8 ± 10C’a 0.3 ± 02B,a
Castration 9-14 1.2±0.3 8.2±O.9Ba
AG treatment (not group 1)
PDS removal
15-24
20-24
0.8 ± 03AB’b
0.4 ± 01AB’b
13.8 ± l.1’”
13.9 ± 1#{149}3A’
0.1 ± 0.04
0.5 ±
Superscripts represent significant differences at the 0.05 level. Uppercase superscripts compare the effect of treatments within
each group (vertical comparison). Lowercase superscripts compare the effect of treatments between the groups (horizontal
comparison).
238 Journal of Andrology . July/August 1986 Vol. 7
Block GJ, MaskenJ, Kragt CL, Ganong WF. Effect of testosterone
TABLE 3. Plasma Concentrations of FSH (ng/ml) in dogs treated with PDS-E2 (Group 1);
Empty PDS + AG (Group 2); and PDS-E2 + AG (Group 3)
Treatment Days
Group 1
(Mean ± SEM)
Group 2
(Mean ± SEM)
Group 3
(Mean ± SEM)
Pretreatment 0-4 177 ± 93B’a, 173 ± 137C’a 1% ± 101A’a
PDS 5-8 167 ± 66B’a 177 ± 99C,a 181 ±
Castration 9-14 173 ± 97B’b 372 ± 239B,a 203 ± 134A’b
AG treatment (not group 1)
PDS removal
15-24
20-24
157 ± 96B’b
210 ± 172A’t,
662 ± 366A’a740 ± 368A’a 200 ± 106A’b
203 ± 103A’b
‘Superscripts represent significant differences at the 0.05 level. Uppercase superscripts compare the effect of treatments within
each group (vertical comparison). Lowercase superscripts compare the effect of treatments between the groups (horizontal compari-
son).
infused with T. Whereas plasma T concentrations
rose following Teslac treatment, plasma E2 concen-
trations remained unchanged. Since LH and FSH
were reduced either under both the Teslac plus T
regimen or when T was infused in the absence of
Teslac, these authors concluded that T directly
altered gonadotropin secretion. However, the possi-
bility that the decrease in gonadotropin secretion was
due to central aromatization of T to E2 was not
excluded. Their experiments could be interpreted as
a reduction in peripheral but not central aromatiza-
tion.
Other data obtained in the male rat (Krey et a!,
1982) contradict those reported for dogs and mon-
keys. Normally, T induces elevations in brain nuclear
estrogen receptor levels. When blockage of central
aromatization via ATD administration was accom-
plished, no rise in plasma LH was observed in T-
implanted castrated male rats. These authors con-
cluded that aromatization was not crucial to gonado-
tropin regulation in the male rat. The reasons for the
different results reported in the dog (Worgul et al,
1981; Winter et al, 1983) and those obtained in the
monkey (Ellinwood et al, 1984), as compared to those
conducted in men (Marynick et al, 1979) and the rat
(Krey et al, 1982), may be threefold: 1) there may be a
species difference in steroid specificity to negative
feedback; 2) the dog and monkey may have different
susceptibilities to centrally inhibited aromatization as
compared to men and rats; and 3) the different aro-
matase inhibitors used and/or their dosages may
have been the cause of the different results. While
further work is required in the male, it is clear from
our studies in male dogs that aromatization is
involved in LH secretion.
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